Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
DATA GRAPHICS | Data Byte

Three radiotherapy companies have raised over $200M in 1Q22 

March fund-raisings equate to over 80% of 2021’s total venture capital raised and almost two-thirds of 2020’s total 

March 29, 2022 12:41 AM UTC

The growing targeted radiotherapy space saw three private biotechs raise venture rounds this month. While the financings were the first disclosed this year for companies focused on radiopharmaceuticals, they put total venture raised by the group at 82% of 2021’s full-year total and 64% of 2020’s total. 

The three financings brought in nearly $205 million, while radiotherapeutics developers raised $250 million in venture funding in 2021 and $321 million in 2020, according to BioCentury’s BCIQ database...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article